Sage shares get a bump from a snapshot of new PhII depression data
Sage Therapeutics $SAGE has had a lot of success posting interim snapshots on the data it’s been gathering for its pipeline drugs. And the biotech …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
